WSG ADAPT - adjuvant dynamic marker-adjusted personalized therapy trial optimizing risk assessment and therapy response prediction in early breast cancer: study protocol for a prospective, multi-center, controlled, non-blinded, randomized, investiga (Q34956588)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | WSG ADAPT - adjuvant dynamic marker-adjusted personalized therapy trial optimizing risk assessment and therapy response prediction in early breast cancer: study protocol for a prospective, multi-center, controlled, non-blinded, randomized, investiga |
scientific article |
Statements
1 reference
WSG ADAPT - adjuvant dynamic marker-adjusted personalized therapy trial optimizing risk assessment and therapy response prediction in early breast cancer: study protocol for a prospective, multi-center, controlled, non-blinded, randomized, investiga (English)
1 reference
Daniel Hofmann
1 reference
Ulrike Nitz
1 reference
Oleg Gluz
1 reference
Ronald E Kates
1 reference
Timo Schinkoethe
1 reference
Peter Staib
1 reference
19 August 2013
1 reference
1 reference
1 reference
Identifiers
1 reference